Opportunity for adults in the UK and diagnosed with cirrhosis to take part in the OPAL observational study sponsored by Resolution Therapeutics.
Advanced cirrhosis can progress in different ways for different people. We do not fully understand how the disease develops after someone has their first liver decompensation event. The OPAL study will collect data from routine hospital visits, medical records, and blood tests. This data will help doctors and scientists understand how to better care for people with advanced cirrhosis. The research may also lead to new medicines and treatments being developed.
Can I take part in OPAL?
OPAL is focused on people with 'decompensated cirrhosis'. If you are interested in taking part you will need to meet certain criteria, including:
* be aged 18-75 years old
* have been diagnosed with liver cirrhosis
* have had a liver decompensation event for the first time in the last 6 weeks
You can see the full eligibility criteria when you click the link below about how to get involved.
What do I have to do if I take part?
The study does not involve you taking any new medicines. Instead it follows the normal care you receive.
You might have extra visits and tests if you do not have a routine appointment booked. This is to make sure that certain routine data is collected at the right time. As a result, you may get more appointments and be more closely monitored by being part of this study.
This will take place over two years. You are free to leave the study at any time without giving a reason.
Are there any costs/payments for taking part in this study?
There will be no cost to you for taking part in this study. You will be able to claim money to cover travel expenses if you need extra clinic visits that do not coincide with your routine appointments.
How do I get involved?
There are currently 9 hospitals across England and Scotland participating in the study. If you are being treated for cirrhosis at one of them and would like to find out more about taking part, please visit: